| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | - | 0 | 631 | 801 | 7.713 | 11.559 |
| Total Income - EUR | - | - | - | - | - | 4.706 | 9.724 | 5.774 | 11.284 | 15.111 |
| Total Expenses - EUR | - | - | - | - | - | 15.533 | 29.207 | 32.708 | 34.343 | 25.234 |
| Gross Profit/Loss - EUR | - | - | - | - | - | -10.827 | -19.483 | -26.934 | -23.059 | -10.122 |
| Net Profit/Loss - EUR | - | - | - | - | - | -10.827 | -19.483 | -26.942 | -23.059 | -10.469 |
| Employees | - | - | - | - | - | 4 | 4 | 4 | 2 | 2 |
Check the financial reports for the company - Natalia Med S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | - | 35.955 | 30.200 | 25.436 | 21.787 | 18.114 |
| Current Assets | - | - | - | - | - | 313 | 6.822 | 2.028 | 2.102 | 2.106 |
| Inventories | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | - | - | - | - | 310 | 1.718 | 1.728 | 1.761 | 0 |
| Cash | - | - | - | - | - | 2 | 5.104 | 300 | 340 | 2.106 |
| Shareholders Funds | - | - | - | - | - | -11.119 | -30.356 | -57.392 | -80.277 | -90.297 |
| Social Capital | - | - | - | - | - | 83 | 81 | 81 | 81 | 80 |
| Debts | - | - | - | - | - | 10.746 | 36.094 | 58.448 | 81.410 | 93.149 |
| Income in Advance | - | - | - | - | - | 36.641 | 31.284 | 26.408 | 22.755 | 17.368 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Natalia Med S.r.l.